Julie Louise Gerberding
Julie Louise Gerberding holds the position of Chief patient officer at Merck & Co., Inc. Dr. Gerberding is also Member of Institute of Medicine and on the board of 7 other companies.
She previously occupied the position of Co-Chairman for MSD Vaccines Ltd., President for Merck Vaccine Division and Director at Centers for Disease Control & Prevention.
Dr. Gerberding received a doctorate and an undergraduate degree from Case Western Reserve University and a graduate degree from the University of California, Berkeley.
|05/19/2021||3,188||Award at $0 per share.||0|
|05/22/2020||3,716||Award at $0 per share.||0|
|08/22/2019||7,928||Disposition at $71.82 per share.||569,389|
|05/30/2019||3,556||Award at $0 per share.||0|
|05/18/2018||4,100||Award at $0 per share.||0|
|05/24/2017||3,900||Award at $0 per share.||0|
|03/03/2017||4,500||Award at $0 per share.||0|